Your browser doesn't support javascript.
loading
Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement.
Pashayan, Nora; Antoniou, Antonis C; Ivanus, Urska; Esserman, Laura J; Easton, Douglas F; French, David; Sroczynski, Gaby; Hall, Per; Cuzick, Jack; Evans, D Gareth; Simard, Jacques; Garcia-Closas, Montserrat; Schmutzler, Rita; Wegwarth, Odette; Pharoah, Paul; Moorthie, Sowmiya; De Montgolfier, Sandrine; Baron, Camille; Herceg, Zdenko; Turnbull, Clare; Balleyguier, Corinne; Rossi, Paolo Giorgi; Wesseling, Jelle; Ritchie, David; Tischkowitz, Marc; Broeders, Mireille; Reisel, Dan; Metspalu, Andres; Callender, Thomas; de Koning, Harry; Devilee, Peter; Delaloge, Suzette; Schmidt, Marjanka K; Widschwendter, Martin.
Afiliação
  • Pashayan N; Department of Applied Health Research, Institute of Epidemiology and Healthcare, University College London, London, UK.
  • Antoniou AC; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Ivanus U; Epidemiology and Cancer Registry, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • Esserman LJ; Carol Franc Buck Breast Care Center, University of California, San Francisco, CA, USA.
  • Easton DF; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • French D; Division of Psychology & Mental Health, School of Health Sciences, University of Manchester, Manchester, UK.
  • Sroczynski G; Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and Health Technology Assessment, UMIT-University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.
  • Hall P; Division of Health Technology Assessment, Oncotyrol - Center for Personalized Cancer Medicine, Innsbruck, Austria.
  • Cuzick J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Evans DG; Department of Oncology, Södersjukhuset, Stockholm, Sweden.
  • Simard J; Wolfson Institute of Preventive Medicine, Barts and The London, Centre for Cancer Prevention, Queen Mary University of London, London, UK.
  • Garcia-Closas M; Division of Evolution and Genomic Sciences, University of Manchester, Manchester, UK.
  • Schmutzler R; Genomics Center, CHU de Québec - Université Laval Research Center, Québec, Canada.
  • Wegwarth O; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Pharoah P; Center of Family Breast and Ovarian Cancer, University Hospital Cologne, Cologne, Germany.
  • Moorthie S; Max Planck Institute for Human Development, Center for Adaptive Rationality, Harding Center for Risk Literacy, Berlin, Germany.
  • De Montgolfier S; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Baron C; Department of Oncology, University of Cambridge, Cambridge, UK.
  • Herceg Z; PHG Foundation, Cambridge, UK.
  • Turnbull C; IRIS Institute for Interdisciplinary Research on Social Issues, Paris, France.
  • Balleyguier C; Unicancer, Paris, France.
  • Rossi PG; Epigenetic Group, International Agency for Research on Cancer (IARC), WHO, Lyon, France.
  • Wesseling J; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
  • Ritchie D; Department Medical Imaging, Institut Gustave Roussy, Villejuif, France.
  • Tischkowitz M; Epidemiology Unit, Azienda USL di Reggio Emilia - IRCCS, Reggio Emilia, Italy.
  • Broeders M; Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
  • Reisel D; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Metspalu A; Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.
  • Callender T; Department for Health Evidence, Radboud University Medical Center, Nijmegen, Netherlands.
  • de Koning H; Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Devilee P; The Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu, Estonia.
  • Delaloge S; Department of Applied Health Research, Institute of Epidemiology and Healthcare, University College London, London, UK.
  • Schmidt MK; Department of Public Health, Erasmus MC, Rotterdam, Netherlands.
  • Widschwendter M; Department of Human Genetics, Department of Pathology, Leiden University Medical Centre, Leiden, Netherlands.
Nat Rev Clin Oncol ; 17(11): 716, 2020 Nov.
Article em En | MEDLINE | ID: mdl-32601456
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article